US Stock MarketDetailed Quotes
AIH Aesthetic Medical International
- 0.4993
- +0.0293+6.23%
Close May 14 16:00 ET
23.86MMarket Cap-4304P/E (TTM)
0.5200High0.4522Low40.80KVolume0.4610Open0.4700Pre Close19.02KTurnover7.03%Turnover RatioLossP/E (Static)47.79MShares1.430052wk High3.54P/B289.62KFloat Cap0.286952wk Low--Dividend TTM580.06KShs Float12.5600Historical High--Div YieldTTM14.43%Amplitude0.2869Historical Low0.4660Avg Price1Lot Size
Aesthetic Medical International Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | 198.88%74.29M | -247.04%-75.13M | 6,160.62%51.09M | -100.97%-843K | 1,672.80%86.76M | -93.64%4.89M | 47.80%76.98M | 52.08M |
| Net income from continuing operations | 41.54%-55.06M | 86.18%-94.17M | -162.56%-681.31M | -270.31%-259.49M | 165.12%152.36M | -340.05%-233.97M | -182.77%-53.17M | --64.24M |
| Operating gains losses | -75.80%8.4M | -5.67%34.72M | 679.72%36.8M | 133.38%4.72M | -170.14%-14.14M | -1,525.47%-5.23M | 79.80%-322K | ---1.59M |
| Depreciation and amortization | 7.17%65.9M | -37.98%61.49M | -6.83%99.14M | 26.92%106.41M | 160.84%83.83M | 10.41%32.14M | -24.83%29.11M | --38.73M |
| Other non cash items | -112.31%-5.91M | 60.84%47.99M | -1.47%29.83M | 119.81%30.28M | -150.73%-152.83M | 130.37%301.25M | 1,912.64%130.76M | ---7.21M |
| Change In working capital | 135.16%53.46M | -169.80%-152.04M | 1,756.60%217.84M | 159.27%11.73M | 69.26%-19.8M | -603.64%-64.4M | 75.06%-9.15M | ---36.7M |
| -Change in receivables | -129.07%-878K | -92.04%3.02M | 1,311.57%37.96M | 125.94%2.69M | 71.73%-10.37M | -508.56%-36.67M | 82.32%-6.03M | ---34.09M |
| -Change in inventory | 4,274.15%12.27M | 63.25%-294K | 91.08%-800K | -195.39%-8.97M | -189.46%-3.04M | 130.95%3.4M | -9,871.82%-10.97M | ---110K |
| -Change in payables and accrued expense | 121.28%18.74M | -85.45%-88.04M | -252.36%-47.48M | 611.83%31.16M | -1.42%-6.09M | -138.17%-6M | 94.73%15.73M | --8.08M |
| -Change in other working capital | 134.96%23.33M | -129.25%-66.73M | 1,835.66%228.15M | -4,224.01%-13.15M | 98.79%-304K | -218.66%-25.12M | 25.48%-7.88M | ---10.58M |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | 198.88%74.29M | -247.04%-75.13M | 6,160.62%51.09M | -100.97%-843K | 1,672.80%86.76M | -93.64%4.89M | 47.80%76.98M | --52.08M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -1,779.40%-52.25M | 126.99%3.11M | 90.95%-11.53M | -11.56%-127.37M | -49.87%-114.17M | -10.10%-76.18M | -78.04%-69.2M | -38.87M |
| Net PPE purchase and sale | -3,358.55%-55.23M | 95.17%-1.6M | 13.75%-33.07M | 44.52%-38.34M | -51.92%-69.11M | 4.22%-45.49M | -22.91%-47.5M | ---38.64M |
| Net intangibles purchase and sale | -165.43%-215K | 60.49%-81K | 96.99%-205K | 1.15%-6.81M | -839.43%-6.89M | -352.47%-733K | 69.55%-162K | ---532K |
| Net business purchase and sale | -90.31%860K | 202.86%8.87M | 82.74%-8.62M | -83.15%-49.96M | -1,229.89%-27.28M | 95.16%-2.05M | ---42.41M | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | 12.90%-21.29M | ---24.44M | --0 | --0 | ---- |
| Net other investing changes | 153.43%2.26M | -114.00%-4.24M | 348.91%30.26M | -192.43%-12.16M | --13.15M | ---- | --20M | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -1,779.40%-52.25M | 126.99%3.11M | 90.95%-11.53M | -11.56%-127.37M | -49.87%-114.17M | -10.10%-76.18M | -78.04%-69.2M | ---38.87M |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | -36.20%29.06M | 200.70%45.55M | -355.61%-45.24M | -77.76%17.7M | 19.21%79.56M | 336.78%66.74M | -148.08%-28.19M | 58.63M |
| Net issuance payments of debt | -285.97%-130.25M | -7.84%-33.75M | -200.44%-31.29M | 134.78%31.16M | -276.55%-89.58M | 363.73%50.74M | -126.68%-19.24M | --72.12M |
| Net common stock issuance | 80.56%170M | --94.15M | --0 | -101.09%-1.98M | 607.82%181.91M | --25.7M | --0 | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | -118.40%-546K | 77.58%-250K | -19.12%-1.12M | 4.68%-936K | -36.20%-982K | 69.54%-721K | 77.61%-2.37M | ---10.57M |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | -36.20%29.06M | 200.70%45.55M | -355.61%-45.24M | -77.76%17.7M | 19.21%79.56M | 336.78%66.74M | -148.08%-28.19M | --58.63M |
| Net cash flow | ||||||||
| Beginning cash position | -69.05%12.16M | -11.48%39.29M | -71.27%44.38M | 51.63%154.49M | -3.89%101.89M | -18.22%106.01M | 114.38%129.63M | --60.47M |
| Current changes in cash | 293.11%51.1M | -366.80%-26.46M | 94.87%-5.67M | -311.92%-110.51M | 1,246.91%52.15M | 77.71%-4.55M | -128.40%-20.4M | --71.85M |
| Effect of exchange rate changes | -39.40%-927K | -215.85%-665K | 40.69%574K | -10.13%408K | -58.27%454K | 133.82%1.09M | -19.86%-3.22M | ---2.68M |
| End cash Position | 412.59%62.34M | -69.05%12.16M | -11.48%39.29M | -71.27%44.38M | 50.65%154.49M | -3.26%102.55M | -18.22%106.01M | --129.63M |
| Free cash flow | 124.51%18.83M | -535.17%-76.8M | 138.36%17.65M | -527.44%-46.01M | 126.03%10.76M | -241.04%-41.36M | 127.12%29.32M | --12.91M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg